| Financial Year |
March 31 2023 |
| Monetary Funds |
1,616,691,163.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,135,481.09 |
| Accounts Receivable |
3,819,414,004.35 |
| Advances to Suppliers |
410,383,628.27 |
| Other Receivables |
224,088,202.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
300,438,374.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,666,001.06 |
| Total Current Assets |
9,845,506,207.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
394,290,481.84 |
| Investment Properties |
39,504,155.67 |
| Fixed Assetes |
353,499,443.76 |
| Under-construction Projects |
270,060.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,367,380.44 |
| R&D expenses |
-- |
| Goodwill |
103,860,149.59 |
| Long-Term Deferred and Prepaid Expenses |
36,259,860.42 |
| Deferred Income Tax Assets |
271,864,274.89 |
| Other Non-Current Assets |
11,848,358.95 |
| Sub-Total of Non-Current Assets |
1,557,986,085.44 |
| Total Assets |
11,403,492,292.92 |
| Short-Term Loans |
259,271,722.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,687,817.67 |
| Accounts Payable |
3,387,485,602.34 |
| Accounts Received In Advance |
7,087,932.92 |
| Employee Compensation Payable |
1,110,242,674.97 |
| Taxes Payable |
310,207,492.51 |
| Interest Payable |
-- |
| Dividend Payable |
5,964,772.72 |
| Other payables |
268,716,685.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,191,071.93 |
| Other Current Liabilities |
71,480,712.69 |
| Sub-Total of Current Liabilities |
6,742,997,347.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,196,917.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
123,600.00 |
| Deferred Income Tax Liabilities |
9,687,658.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,690,549.75 |
| Total Liabilities |
6,810,687,897.32 |
| Paid-In Capital(Or Share Stock) |
683,780,952.00 |
| Capital Surplus |
550,544,009.44 |
| Surplus Reserve |
337,014,467.92 |
| LESS:Treasury Stock |
84,883,906.00 |
| Undistributed Profits |
3,009,695,145.62 |
| Minority Stockholder's Interest |
96,653,726.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,496,150,668.98 |
| Owner's Equity（Stockholder's Equity） |
4,592,804,395.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,403,492,292.92 |
